BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 1928617)

  • 1. Nucleolar organizer regions in malignant melanoma and melanocytic nevi. Comparison of two counting methods.
    Di Gregorio C; Losi L; Annessi G; Botticelli A
    Am J Dermatopathol; 1991 Aug; 13(4):329-33. PubMed ID: 1928617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nucleolar organizer regions in pigmented skin lesions. Value in the differential diagnosis of Spitz nevi.
    González-Cámpora R; Armas-Padrón JR; Rios-Martín JJ; López-Garrido J; Gómez-Pascual A; Galera-Davidson H
    Anal Quant Cytol Histol; 1991 Feb; 13(1):16-22. PubMed ID: 1709022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silver staining of nucleolar organizer regions in malignant melanoma and melanotic nevi.
    Leong AS; Gilham P
    Hum Pathol; 1989 Mar; 20(3):257-62. PubMed ID: 2470664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleolar organizer regions in Spitz nevi and malignant melanomas.
    Howat AJ; Giri DD; Cotton DW; Slater DN
    Cancer; 1989 Feb; 63(3):474-8. PubMed ID: 2912525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AgNOR area measurements differentiate benign and malignant melanocytic lesions more accurately than simple counting.
    Gonzalez AP; Kumar D; Sánchez RL
    Am J Dermatopathol; 1994 Aug; 16(4):372-6. PubMed ID: 7526724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AgNORs in benign, dysplastic, and malignant melanocytic skin lesions.
    Howat AJ; Wright AL; Cotton DW; Reeve S
    Am J Dermatopathol; 1990 Apr; 12(2):156-61. PubMed ID: 2331050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An assessment of the value of Ag NOR staining in the identification of dysplastic and other borderline melanocytic naevi.
    MacKie RM; White SI; Seywright MM; Young H
    Br J Dermatol; 1989 Apr; 120(4):511-6. PubMed ID: 2471546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognosing melanomas: the argyrophilic nucleolar organizer region approach.
    Rebora A
    Dermatology; 1992; 185(3):166-8. PubMed ID: 1446080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re-evaluating silver-stained nucleolar organizer regions (AgNORs) in problematic cutaneous melanocytic lesions: a study with quantitation and pattern analysis.
    Evans AT; Orrell JM; Grant A
    J Pathol; 1991 Sep; 165(1):61-7. PubMed ID: 1955937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AgNOR (nucleolar organizer regions) staining in malignant melanoma.
    Nagatani T; Iemoto G; Miyakawa K; Ichiyama S; Takahashi Y; Uchiyama M; Nakajima H
    J Dermatol; 1991 Dec; 18(12):731-5. PubMed ID: 1806604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Quantitative analysis of nucleolar organizer regions in nevi and melanomas].
    Dujela N
    Lijec Vjesn; 1993; 115(7-8):241-3. PubMed ID: 8139368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Argyrophilic staining of nucleolar organizer region count and morphometry in benign and malignant melanocytic lesions.
    Li LX; Crotty KA; Palmer AA; Kril JJ; Scolyer RA; Thompson JF; McCarthy SW
    Am J Dermatopathol; 2003 Jun; 25(3):190-7. PubMed ID: 12775980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A critical evaluation of AgNOR counting in benign naevi and malignant melanoma.
    Orrell JM; Evans AT; Grant A
    J Pathol; 1991 Mar; 163(3):239-44. PubMed ID: 1707452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleolar organizer regions in iris nevi and melanomas.
    Marcus DM; Mawn LA; Egan KM; Albert DM
    Am J Ophthalmol; 1992 Aug; 114(2):202-7. PubMed ID: 1642296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of nucleolar organizer regions (NORS) in malignant melanoma.
    Ronan SG; Farolan MJ; McDonald A; Manaligod JR; Das Gupta TK
    J Cutan Pathol; 1994 Dec; 21(6):494-9. PubMed ID: 7699115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silver staining nucleolar organiser region (AgNOR) study in melanocytic skin tumours.
    Naik R; Raghuveer CV; Jacob DL
    J Indian Med Assoc; 1997 Jul; 95(7):420-1. PubMed ID: 9425842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleolar organizer regions in determining malignancy of pigmented conjunctival lesions.
    Saornil MA; Marcus DM; Doepner D; Apolone G; Torre V; Albert DM
    Am J Ophthalmol; 1993 Jun; 115(6):800-5. PubMed ID: 8506916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nucleolar organizer regions argyrophilic associated proteins in cutaneous melanocytic lesions.
    Reis JP; Tellechea O; Baptista AP
    Dermatologica; 1991; 183(2):136-8. PubMed ID: 1743375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinguishing benign and malignant melanocytic lesions with the AgNOR method.
    Friedman RJ; Grin CM; Heilman E; Weiser J; Gottlieb GJ; Waldo E; Rigel DS; Kopf AW
    Dermatol Clin; 1991 Oct; 9(4):689-93. PubMed ID: 1934643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PCNA expression and nucleolar organizer regions in malignant melanoma and nevus cell nevus.
    Kanoko M; Ueda M; Ichihashi M
    Kobe J Med Sci; 1994 Aug; 40(3-4):107-23. PubMed ID: 7739200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.